Alzheimer's Disease and Specialized Pro-Resolving Lipid Mediators: Do MaR1, RvD1, and NPD1 Show Promise for Prevention and Treatment?

Miyazawa, K; Fukunaga, H; Tatewaki, Y; Takano, Y; Yamamoto, S; Mutoh, T; Taki, Y

Fukunaga, H; Tatewaki, Y (corresponding author), Tohoku Univ, Inst Dev Aging & Canc, Dept Nucl Med & Radiol, Sendai, Miyagi 9808575, Japan.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020; 21 (16):

Abstract

Alzheimer's disease (AD) is a common neurodegenerative disease and a major contributor to progressive cognitive impairment in an aging society. As the......

Full Text Link